SG143257A1 - Pregabalin composition - Google Patents

Pregabalin composition

Info

Publication number: SG143257A1
Authority: SG; Singapore
Prior art keywords: pregabalin; composition; pharmaceutical composition; liquid; pregabalin composition
Prior art date: 2003-12-18

Application number

SG200803603-0A

Other languages

English (en)

Inventor

Michael Schneider

Hans Richard Meyer-Wonnay

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-18

Filing date

2004-12-06

Publication date

2008-06-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34486238&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG143257(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-06 Application filed by Pfizer filed Critical Pfizer

2008-06-27 Publication of SG143257A1 publication Critical patent/SG143257A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

SG200803603-0A 2003-12-18 2004-12-06 Pregabalin composition SG143257A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03029117A EP1543831A1 (fr)	2003-12-18	2003-12-18	Composition de pregabaline

Publications (1)

Publication Number	Publication Date
SG143257A1 true SG143257A1 (en)	2008-06-27

Family

ID=34486238

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG200803603-0A SG143257A1 (en)	2003-12-18	2004-12-06	Pregabalin composition
SG200705273-1A SG136119A1 (en)	2003-12-18	2004-12-06	Pregabalin composition

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG200705273-1A SG136119A1 (en)	2003-12-18	2004-12-06	Pregabalin composition

Country Status (17)

Country	Link
US (1)	US20050171203A1 (fr)
EP (2)	EP1543831A1 (fr)
JP (1)	JP2007514728A (fr)
KR (1)	KR100841893B1 (fr)
CN (1)	CN1893938A (fr)
AU (1)	AU2004308747A1 (fr)
BR (1)	BRPI0417585A (fr)
CA (1)	CA2549599A1 (fr)
IL (1)	IL176129A0 (fr)
MX (1)	MXPA06006811A (fr)
MY (1)	MY143561A (fr)
NO (1)	NO20063178L (fr)
RU (1)	RU2352333C2 (fr)
SG (2)	SG143257A1 (fr)
TW (1)	TWI279230B (fr)
WO (1)	WO2005063229A1 (fr)
ZA (1)	ZA200604656B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9710536A (pt)	1996-07-24	1999-08-17	Warner Lambert Co	Isobutilgaba e seus derivados para o tratamento da dor
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
EP2246044A1 (fr) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Solutions pédiatriques de bêta-bloquants
WO2010150221A1 (fr)	2009-06-25	2010-12-29	Wockhardt Research Centre	Compositions pharmaceutiques de prégabaline de saveur masquée
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
EA017542B1 (ru) *	2011-05-24	2013-01-30	Плива Кроэйша Лтд.	Стабильная фармацевтическая композиция, содержащая прегабалин, капсула, ее содержащая, способ получения и применение
EA020558B1 (ru) *	2012-03-20	2014-12-30	ООО "Эн.Си. ФАРМ"	Фармацевтический состав, обладающий нейропротекторной, антиамнестической, антиоксидантной, противогипоксической, нейрометаболической, противоишемической активностью (варианты)
US9937153B2 (en)	2013-08-30	2018-04-10	Merck Sharp & Dohme Ltd.	Oral pharmaceutical formulation of omarigliptin
GR1009462B (el) *	2017-10-05	2019-02-15	Laboserve Φαρμακευτικη Βιομηχανια Α.Ε.	Ποσιμο φαρμακευτικο διαλυμα με συγκαλυμμενη γευση
CN107998074A (zh) *	2017-12-13	2018-05-08	广州大光制药有限公司	普瑞巴林口服溶液及其制备方法
CN110693820A (zh) *	2018-07-10	2020-01-17	北京万全德众医药生物技术有限公司	普瑞巴林口服溶液及其制备方法
MX2021011550A (es)	2019-03-26	2021-10-26	Orion Corp	Formulaciones de pregabalina y uso de las mismas.
CN112107537A (zh) *	2019-06-19	2020-12-22	北京万全德众医药生物技术有限公司	一种普瑞巴林口服溶液及其制备方法
CN111855828B (zh) *	2020-02-28	2022-07-01	中国人民解放军军事科学院军事医学研究院	一种同时测定普瑞巴林以及羟苯酯类抑菌剂含量的方法
CN113616591B (zh) *	2021-09-03	2023-05-23	贝克诺顿(浙江)制药有限公司	一种普瑞巴林口服溶液及制备方法
GB2624861A (en)	2022-11-28	2024-06-05	Orbit Pharma Ltd	Sustained release pharmaceutical compositions comprising pregabalin or pharmaceutically acceptable salts thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6197819B1 (en) *	1990-11-27	2001-03-06	Northwestern University	Gamma amino butyric acid analogs and optical isomers
US5616793A (en) *	1995-06-02	1997-04-01	Warner-Lambert Company	Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) *	1995-06-07	1997-06-10	Warner-Lambert Company	Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
HRP980342A2 (en) *	1997-06-25	1999-02-28	Warner Lambert Co	Anti-inflammatory method
SK19992000A3 (sk) *	1998-06-22	2001-08-06	American Biogenetic Sciences, Inc.	Použitie kyseliny 2-n-propyl-4-hexínovej na liečenie a prevenciu migrény a afektívneho ochorenia
AP2002002501A0 (en) *	1999-10-07	2002-06-30	Warner Lambert Co	Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
MXPA02007307A (es) *	2000-01-27	2002-11-29	Warner Lambert Co	Sintesis asimetrica de pregabalin.
PL366384A1 (en) *	2001-05-25	2005-01-24	Warner-Lambert Company Llc	Liquid pharmaceutical composition
US6818787B2 (en) *	2001-06-11	2004-11-16	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
WO2003080588A1 (fr) *	2002-03-20	2003-10-02	Xenoport	Promedicaments 1-(acyloxy)-alkyle cyclique d'analogues de l'acide gamma-aminobutyrique, leurs compositions et leurs utilisations

2003
- 2003-12-18 EP EP03029117A patent/EP1543831A1/fr not_active Withdrawn
2004
- 2004-12-06 BR BRPI0417585-9A patent/BRPI0417585A/pt not_active IP Right Cessation
- 2004-12-06 WO PCT/IB2004/004029 patent/WO2005063229A1/fr active Application Filing
- 2004-12-06 AU AU2004308747A patent/AU2004308747A1/en not_active Abandoned
- 2004-12-06 MX MXPA06006811A patent/MXPA06006811A/es unknown
- 2004-12-06 SG SG200803603-0A patent/SG143257A1/en unknown
- 2004-12-06 CN CNA2004800374979A patent/CN1893938A/zh active Pending
- 2004-12-06 RU RU2006120946/15A patent/RU2352333C2/ru not_active IP Right Cessation
- 2004-12-06 SG SG200705273-1A patent/SG136119A1/en unknown
- 2004-12-06 EP EP04801336A patent/EP1722773A1/fr not_active Withdrawn
- 2004-12-06 CA CA002549599A patent/CA2549599A1/fr not_active Abandoned
- 2004-12-06 JP JP2006544577A patent/JP2007514728A/ja not_active Withdrawn
- 2004-12-06 KR KR1020067011926A patent/KR100841893B1/ko not_active IP Right Cessation
- 2004-12-17 TW TW093139422A patent/TWI279230B/zh not_active IP Right Cessation
- 2004-12-17 US US11/016,511 patent/US20050171203A1/en not_active Abandoned
- 2004-12-17 MY MYPI20045225A patent/MY143561A/en unknown
2006
- 2006-06-05 IL IL176129A patent/IL176129A0/en unknown
- 2006-06-07 ZA ZA200604656A patent/ZA200604656B/xx unknown
- 2006-07-07 NO NO20063178A patent/NO20063178L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2006120946A (ru)	2008-01-27
RU2352333C2 (ru)	2009-04-20
CA2549599A1 (fr)	2005-07-14
ZA200604656B (en)	2007-10-31
KR100841893B1 (ko)	2008-06-26
TW200520751A (en)	2005-07-01
AU2004308747A1 (en)	2005-07-14
JP2007514728A (ja)	2007-06-07
EP1722773A1 (fr)	2006-11-22
MXPA06006811A (es)	2006-08-23
KR20060103336A (ko)	2006-09-28
CN1893938A (zh)	2007-01-10
TWI279230B (en)	2007-04-21
BRPI0417585A (pt)	2007-03-13
WO2005063229A1 (fr)	2005-07-14
NO20063178L (no)	2006-06-19
EP1543831A1 (fr)	2005-06-22
IL176129A0 (en)	2006-10-05
US20050171203A1 (en)	2005-08-04
MY143561A (en)	2011-05-31
SG136119A1 (en)	2007-10-29

Publication	Publication Date	Title
MY143561A (en)	2011-05-31	Pregabalin composition
PT1413582E (pt)	2006-07-31	Pirrolobenzodiazepinas dimericas
MXPA05001841A (es)	2005-09-30	Formulacion de anticuerpos humanos para tratar trastornos asociados con tnfa.
WO2003051293A3 (fr)	2003-10-30	Formulation anti-diabete et procede
FR2848116B1 (fr)	2007-01-05	Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
EP1295879A4 (fr)	2004-04-14	Compositions medicinales contenant des derives de propenone
EP1522898A3 (fr)	2005-09-14	Régénérateur pour révélateur
HRP20010238B1 (en)	2006-05-31	2-methyl-thieno-benzodiazepine formulation
IS6654A (is)	2002-12-11	Stöðugt gabapentín með pH innan stýrðra marka
BR0308170A (pt)	2005-01-04	Composição para limpeza lìquida aquosa, método para limpeza de um substrato, e, uso de um polioxometalato
GT200200015A (es)	2003-01-31	Formulacion agroquimica
AU2003292006A1 (en)	2004-06-03	3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
CA2438622A1 (fr)	2002-09-12	Compositions contenant de la creatine et de la creatinine
RS50345B (sr)	2009-11-10	Vodena farmaceutska kompozicija koja sadrži ciklesonid
CY1110841T1 (el)	2015-06-10	Σταθεροποιημενος φαρμακευτικος παραγοντας λευκοτριενιου β4 (ltb4)
WO2003048342A3 (fr)	2004-06-10	Compositions de levure liquides
EA199900962A1 (ru)	2000-08-28	Композиция солюбилизированного сертралина
WO2002057246A3 (fr)	2002-11-21	Inhibiteurs de la cruzipaine et d'autres cysteines proteases
EA200300128A1 (ru)	2003-08-28	Фармацевтические композиции, содержащие карбонат лития
AU8678682A (en)	1983-02-10	Aminoglycoside derivatives
PT1305033E (pt)	2005-01-31	Composicoes farmaceuticas que contem tobramicina e goma de xantano
AU7028798A (en)	1998-09-22	Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
WO2002057248A3 (fr)	2002-10-03	Inhibiteurs de la cruzipain et autres cysteine proteases
PT1299114E (pt)	2005-11-30	Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
ES1046918U (es)	2001-02-01	Jeringuilla perfeccionada.